Have you or your loved ones been diagnosed with community-acquired pneumonia?

You may be eligible to participate in a community-acquired pneumonia clinical trial.

Have you or your loved ones been diagnosed with community-acquired pneumonia? You may be eligible to participate in a community-acquired pneumonia clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Community-Acquired Pneumonia Clinical Trial in Brest
NCT02668237 | Interventional

Have you or your loved ones been diagnosed with community-acquired pneumonia?

You may be eligible to participate in a community-acquired pneumonia clinical trial.

Have you or your loved ones been diagnosed with community-acquired pneumonia? You may be eligible to participate in a community-acquired pneumonia clinical trial.

Completed

Male & Female

3 Months -
18 Years

This study has recruited 500 Participants

Community-Acquired Pneumonia (CAP) of children are a recurrent pathology with multiple severity scores. The etiology is never really identified, and the initial treatment is always based on probabilistic antibiotics, in the case of an bacterial infection, and by the way, potentially severe. Molecular tests ("multiplex") allow the simultaneous detection of a huge number of pathogenic agents, virus and bacteria, are now available. This project is based on a new strategy of diagnostic, using a multiplex PCR with quick results, coupled to an antigenic urinary test to allow a complete, quick, etiologic diagnostic as soon as children are supported in emergency. Children are randomized in two groups during inclusions : quick diagnostic strategy versus usual practice. Analyse will be centralized on anti-infectious treatment optimization, with the aim to better treat patients, minimize the costs, and decrease selection pressure of multi-resistant bacteria.